Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SNPs in disease gene mapping, medicinal drug development and evolution.

Journal of human genetics - 1 Jan 2007

Shastry Barkur S

Abstract excerpt

Single nucleotide polymorphism (SNP) technologies can be used to identify disease-causing genes in humans and to understand the inter-individual variation in drug response. These areas of research have major medical benefits. By establishing an association between the genetic make-up of an individual and drug response it may be possible to develop a genome-based diet and medicines that are more effective and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Sequence
Share to Drug Design
Share to Genetic Diseases, Inborn

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Sequence Data

Share to Polymorphism, Single Nucleotide

Share to Sequence Homology, Amino Acid

Source

Identifiers

PMID: 17928948
DOI: 10.1007/s10038-007-0200-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SNPs in disease gene mapping, medicinal drug development and evolution.PMID 17928948Read ↗

SNP alleles in human disease and evolution.Semantic proximity Read ↗

Genetic polymorphisms and implications for human diseases.Semantic proximity Read ↗

Role of single nucleotide polymorphisms in pharmacogenomics and their association with human diseases.Semantic proximity Read ↗

SNP technologies for drug discovery: a current review.Semantic proximity Read ↗

The role of single nucleotide polymorphisms (SNPs) in understanding complex disorders and pharmacogenomics.Semantic proximity Read ↗

Single nucleotide polymorphism and its dynamics for pharmacogenomics.Semantic proximity Read ↗

SNPs: At the origins of the databases of an innovative biotechnology tool.Semantic proximity Read ↗

Using genetic variation to study human disease.Semantic proximity Read ↗

[SNP collection, pharmacogenomics, and the future of drug therapy].Semantic proximity Read ↗

Candidate genes and single nucleotide polymorphisms (SNPs) in the study of human disease.Semantic proximity Read ↗

SNPs and haplotypes: genetic markers for disease and drug response (review).Semantic proximity Read ↗

Genome-based pharmacogenetics and the pharmaceutical industry.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.